A Framework to Understand Uncertainty in Healthcare
Today healthcare is seen as more a science than an art, but the progenitors of healthcare saw it as both ...
When Science Speaks, Who Is The Speaker?
When science speaks, who is the speaker? Can science maintain the objectivity and credibility needed to impact patient behavior if ...
Quality In Healthcare – A Relationship, Not A Metric
In healthcare, we often conflate the validity of a process with the success of its outcome. And in today’s world ...
A Patient Named Candide
A satirical tale inspired by the novella, Candide by the French philosopher Voltaire, reimagines Candide as a patient in today's ...
Fractals May Be The Missing Piece To COVID-19 Projections
Uncertainty and complexity have been the two most prominent features of COVID-19, confounding those who seek to understand and predict ...
Crime & Deterrence – The Constitutional Crisis of the Opioid Epidemic
As the opioid epidemic continues to affect lives across the country, law enforcement steps up their efforts to curtail the ...
Healthcare is a Game of Incomplete Dominance
Healthcare should be studied within the framework of the economic discipline, Game Theory, in which different perspectives or decisions have ...
Healthcare Is Dialectic
Healthcare is defined by strongly held views that quickly develop and come into conflict with opposing views that form just ...
The BOP In The Age of Corona
A gritty tale of life inside a federal prison as inmates face and attempt to understand COVID-19 risks.
Observer Bias Defines How We Look At Ourselves
Observer bias defines the reality we create and the narratives we tell, which may impact how we see the future.
The Perception of COVID-19 Can Impact The Presidential Election
Perception can be greater than reality, but can the perception of COVID-19 impact the reality of the election results this ...
Abortion Laws Are Fundamentally Unconstitutional
Abortion laws should be restructured to be less restrictive in nature and more affirmative - as per our founding father, ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape
-
Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.
-
State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete
-
Chronic Care Toolbox
-
The Importance of Access Control in the Workplace
